Evidence map›Paper›PMID 37064589›Full record

ArticleNeurology. Clinical practice2023

Inequities in Telemedicine Use Among Patients With Stroke and Cerebrovascular Diseases: A Tricenter Cross-sectional Study.

Imama A Naqvi, Audrey S Cohen, Youngran Kim, Jennifer Harris, Mary Carter Denny, Kevin Strobino, Nathan Bicher, Ryan A Leite, Dylan Sadowsky, Comfort Adegboye and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurology. Clinical practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Imama A NaqviDepartment of Neurology (IAN, KS, RSM), Division of Stroke and Cerebrovascular Diseases, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY; Department of Neurology (ASC, YK, NO, MO, SIS, AS) and Institute for Stroke and Cerebrovascular Disease, McGovern Medical School, The University of Texas Health Science Center at Houston, TX; Department of Neurology (JH), Division of Stroke and Cerebrovascular Disease, Cedar-Sinai Medical Center, Los Angeles, CA; Department of Neurology (MCD, NB, RAL, DS), Georgetown University Medical Center and MedStar Georgetown University Hospital, Washington, DC; Howard University (CA), Washington, DC.
Audrey S CohenDepartment of Neurology (IAN, KS, RSM), Division of Stroke and Cerebrovascular Diseases, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY; Department of Neurology (ASC, YK, NO, MO, SIS, AS) and Institute for Stroke and Cerebrovascular Disease, McGovern Medical School, The University of Texas Health Science Center at Houston, TX; Department of Neurology (JH), Division of Stroke and Cerebrovascular Disease, Cedar-Sinai Medical Center, Los Angeles, CA; Department of Neurology (MCD, NB, RAL, DS), Georgetown University Medical Center and MedStar Georgetown University Hospital, Washington, DC; Howard University (CA), Washington, DC.
Youngran KimDepartment of Neurology (IAN, KS, RSM), Division of Stroke and Cerebrovascular Diseases, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY; Department of Neurology (ASC, YK, NO, MO, SIS, AS) and Institute for Stroke and Cerebrovascular Disease, McGovern Medical School, The University of Texas Health Science Center at Houston, TX; Department of Neurology (JH), Division of Stroke and Cerebrovascular Disease, Cedar-Sinai Medical Center, Los Angeles, CA; Department of Neurology (MCD, NB, RAL, DS), Georgetown University Medical Center and MedStar Georgetown University Hospital, Washington, DC; Howard University (CA), Washington, DC.
Jennifer HarrisDepartment of Neurology (IAN, KS, RSM), Division of Stroke and Cerebrovascular Diseases, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY; Department of Neurology (ASC, YK, NO, MO, SIS, AS) and Institute for Stroke and Cerebrovascular Disease, McGovern Medical School, The University of Texas Health Science Center at Houston, TX; Department of Neurology (JH), Division of Stroke and Cerebrovascular Disease, Cedar-Sinai Medical Center, Los Angeles, CA; Department of Neurology (MCD, NB, RAL, DS), Georgetown University Medical Center and MedStar Georgetown University Hospital, Washington, DC; Howard University (CA), Washington, DC.
Mary Carter DennyDepartment of Neurology (IAN, KS, RSM), Division of Stroke and Cerebrovascular Diseases, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY; Department of Neurology (ASC, YK, NO, MO, SIS, AS) and Institute for Stroke and Cerebrovascular Disease, McGovern Medical School, The University of Texas Health Science Center at Houston, TX; Department of Neurology (JH), Division of Stroke and Cerebrovascular Disease, Cedar-Sinai Medical Center, Los Angeles, CA; Department of Neurology (MCD, NB, RAL, DS), Georgetown University Medical Center and MedStar Georgetown University Hospital, Washington, DC; Howard University (CA), Washington, DC.
Kevin StrobinoDepartment of Neurology (IAN, KS, RSM), Division of Stroke and Cerebrovascular Diseases, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY; Department of Neurology (ASC, YK, NO, MO, SIS, AS) and Institute for Stroke and Cerebrovascular Disease, McGovern Medical School, The University of Texas Health Science Center at Houston, TX; Department of Neurology (JH), Division of Stroke and Cerebrovascular Disease, Cedar-Sinai Medical Center, Los Angeles, CA; Department of Neurology (MCD, NB, RAL, DS), Georgetown University Medical Center and MedStar Georgetown University Hospital, Washington, DC; Howard University (CA), Washington, DC.
Nathan BicherDepartment of Neurology (IAN, KS, RSM), Division of Stroke and Cerebrovascular Diseases, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY; Department of Neurology (ASC, YK, NO, MO, SIS, AS) and Institute for Stroke and Cerebrovascular Disease, McGovern Medical School, The University of Texas Health Science Center at Houston, TX; Department of Neurology (JH), Division of Stroke and Cerebrovascular Disease, Cedar-Sinai Medical Center, Los Angeles, CA; Department of Neurology (MCD, NB, RAL, DS), Georgetown University Medical Center and MedStar Georgetown University Hospital, Washington, DC; Howard University (CA), Washington, DC.
Ryan A LeiteDepartment of Neurology (IAN, KS, RSM), Division of Stroke and Cerebrovascular Diseases, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY; Department of Neurology (ASC, YK, NO, MO, SIS, AS) and Institute for Stroke and Cerebrovascular Disease, McGovern Medical School, The University of Texas Health Science Center at Houston, TX; Department of Neurology (JH), Division of Stroke and Cerebrovascular Disease, Cedar-Sinai Medical Center, Los Angeles, CA; Department of Neurology (MCD, NB, RAL, DS), Georgetown University Medical Center and MedStar Georgetown University Hospital, Washington, DC; Howard University (CA), Washington, DC.
Dylan SadowskyDepartment of Neurology (IAN, KS, RSM), Division of Stroke and Cerebrovascular Diseases, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY; Department of Neurology (ASC, YK, NO, MO, SIS, AS) and Institute for Stroke and Cerebrovascular Disease, McGovern Medical School, The University of Texas Health Science Center at Houston, TX; Department of Neurology (JH), Division of Stroke and Cerebrovascular Disease, Cedar-Sinai Medical Center, Los Angeles, CA; Department of Neurology (MCD, NB, RAL, DS), Georgetown University Medical Center and MedStar Georgetown University Hospital, Washington, DC; Howard University (CA), Washington, DC.
Comfort AdegboyeDepartment of Neurology (IAN, KS, RSM), Division of Stroke and Cerebrovascular Diseases, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY; Department of Neurology (ASC, YK, NO, MO, SIS, AS) and Institute for Stroke and Cerebrovascular Disease, McGovern Medical School, The University of Texas Health Science Center at Houston, TX; Department of Neurology (JH), Division of Stroke and Cerebrovascular Disease, Cedar-Sinai Medical Center, Los Angeles, CA; Department of Neurology (MCD, NB, RAL, DS), Georgetown University Medical Center and MedStar Georgetown University Hospital, Washington, DC; Howard University (CA), Washington, DC.
Nnedinma OkpalaDepartment of Neurology (IAN, KS, RSM), Division of Stroke and Cerebrovascular Diseases, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY; Department of Neurology (ASC, YK, NO, MO, SIS, AS) and Institute for Stroke and Cerebrovascular Disease, McGovern Medical School, The University of Texas Health Science Center at Houston, TX; Department of Neurology (JH), Division of Stroke and Cerebrovascular Disease, Cedar-Sinai Medical Center, Los Angeles, CA; Department of Neurology (MCD, NB, RAL, DS), Georgetown University Medical Center and MedStar Georgetown University Hospital, Washington, DC; Howard University (CA), Washington, DC.
Munachi OkpalaDepartment of Neurology (IAN, KS, RSM), Division of Stroke and Cerebrovascular Diseases, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY; Department of Neurology (ASC, YK, NO, MO, SIS, AS) and Institute for Stroke and Cerebrovascular Disease, McGovern Medical School, The University of Texas Health Science Center at Houston, TX; Department of Neurology (JH), Division of Stroke and Cerebrovascular Disease, Cedar-Sinai Medical Center, Los Angeles, CA; Department of Neurology (MCD, NB, RAL, DS), Georgetown University Medical Center and MedStar Georgetown University Hospital, Washington, DC; Howard University (CA), Washington, DC.
Sean I SavitzDepartment of Neurology (IAN, KS, RSM), Division of Stroke and Cerebrovascular Diseases, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY; Department of Neurology (ASC, YK, NO, MO, SIS, AS) and Institute for Stroke and Cerebrovascular Disease, McGovern Medical School, The University of Texas Health Science Center at Houston, TX; Department of Neurology (JH), Division of Stroke and Cerebrovascular Disease, Cedar-Sinai Medical Center, Los Angeles, CA; Department of Neurology (MCD, NB, RAL, DS), Georgetown University Medical Center and MedStar Georgetown University Hospital, Washington, DC; Howard University (CA), Washington, DC.
Randolph S MarshallDepartment of Neurology (IAN, KS, RSM), Division of Stroke and Cerebrovascular Diseases, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY; Department of Neurology (ASC, YK, NO, MO, SIS, AS) and Institute for Stroke and Cerebrovascular Disease, McGovern Medical School, The University of Texas Health Science Center at Houston, TX; Department of Neurology (JH), Division of Stroke and Cerebrovascular Disease, Cedar-Sinai Medical Center, Los Angeles, CA; Department of Neurology (MCD, NB, RAL, DS), Georgetown University Medical Center and MedStar Georgetown University Hospital, Washington, DC; Howard University (CA), Washington, DC.
Anjail SharriefDepartment of Neurology (IAN, KS, RSM), Division of Stroke and Cerebrovascular Diseases, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY; Department of Neurology (ASC, YK, NO, MO, SIS, AS) and Institute for Stroke and Cerebrovascular Disease, McGovern Medical School, The University of Texas Health Science Center at Houston, TX; Department of Neurology (JH), Division of Stroke and Cerebrovascular Disease, Cedar-Sinai Medical Center, Los Angeles, CA; Department of Neurology (MCD, NB, RAL, DS), Georgetown University Medical Center and MedStar Georgetown University Hospital, Washington, DC; Howard University (CA), Washington, DC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: In response to the COVID-19 pandemic, outpatient stroke care delivery was rapidly transformed to outpatient evaluation through video (VTM) and telephone (TPH) telemedicine (TM) visits around the world. We sought to evaluate the sociodemographic differences in outpatient TM use among stroke patients. Methods: We conducted a retrospective chart review of outpatients evaluated at 3 tertiary stroke centers in the early period of the pandemic, 3/16/2020 through 7/31/2020. We compared the use of TM by patient characteristics including age, sex, race/ethnicity, insurance status, stroke type, patient type, and site. The association between TM use and patient characteristics was measured using the relative risk (RR) from a modified Poisson regression, and site-specific effects were controlled using a multilevel analysis. Results: A total of 2,024 visits were included from UTHealth (n = 878), MedStar Health (n = 269), and Columbia (n = 877). The median age was 64 [IQR 52-74] years, and 53% were female. Approximately half of the patients had private insurance, 36% had Medicare, and 15% had Medicaid. Two-thirds of the visits were established patients. TM accounted for 90% of total visits, and the use of TM over office visits was primarily associated with site, not patient characteristics. TM utilization was associated with Asian and other/unknown race. Among TM users, older age, Black race, Hispanic ethnicity, and Medicaid insurance were associated with lower VTM use. Black (aRR 0.88, 95% CI 0.86-0.91, Discussion: In our diverse cohort across 3 centers, we found differences in TM visit type by race and insurance early during the COVID-19 pandemic. These findings suggest disparities in VTM access across different stroke populations. As VTM remains an integral part of outpatient neurology practice, steps to ensure equitable access are essential.

Identifiers

PMID37064589
PMCPMC10101710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.